Eli Lilly and Company (LLY.F)
Develops and sells medicines for diabetes, cancer, autoimmune diseases, and Alzheimer's.
1,070.20-0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+62.1%
The outlook
Eli Lilly trades at 1070.2, sitting near its 52-week high with price above both its 50- and 200-day moving averages. The stock carries a trailing P/E of 43.1, reflecting elevated valuation. Current data shows strong upward positioning in its recent trend, though analyst coverage details weren't provided.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range97% of the way from its 52-week low to high
Market cap
$954.34B
52-wk high
1,085.00
52-wk low
537.40
50-day avg
996.59
200-day avg
886.59
Trailing P/E
43.1